Hepatitis B virus pX activates NF-κB-dependent transcription through a raf-independent pathway

Journal of Virology

Volumn 70, Issue 1, 1996, Pages 641-646

  Chirillo, Paolo ^a   Falco, Mirella ^a   Puri, Pier Lorenzo ^a   Artini, Marco ^a   Balsano, Clara ^a,b   Levrero, Massimo ^a,c,d   Natoli, Gioacchino ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d POLICLINICO UMBERTO I   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ACETYLCYSTEINE; CALPHOSTIN C; DNA; GROWTH FACTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXYGEN RADICAL; PHORBOL ESTER; PROTEIN KINASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR; TYRPHOSTIN;

ARTICLE; CONTROLLED STUDY; GENE; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TRANSACTIVATION;

BASE SEQUENCE; DNA-BINDING PROTEINS; HELA CELLS; HUMAN; MOLECULAR SEQUENCE DATA; NF-KAPPA B; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RAF; SIGNAL TRANSDUCTION; SUPPORT, NON-U.S. GOV'T; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TUMOR CELLS, CULTURED;

EID: 0029656133     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.1.641-646.1996     Document Type: Article

References (58)

1. Arima, N., J. A. Molitor, M. R. Smith, J. H. Kim, Y. Daitoku, and W. C. Greene. 1991. Human T-cell leukemia virus type I tax induces expression of the Rel-related family of κB enhancer-binding proteins: evidence for a pretranslational component of regulation. J. Virol. 65:6892-6899.
2. Aufiero, B., and R. J. Schneider. 1990. The hepatitis B virus X gene product trans-activates both RNA polymerase II and III promoters. EMBO J. 9:497-504.
3. Avantaggiati, M. L., G. Natoli, C. Balsano, P. Chirillo, M. Artini, E. De Marzio, D. Collepardo, and M. Levrero. 1993 The hepatitis B virus pX transactivates the c-fos promoter through multiple cis-acting elements. Oncogene 8:1567-1574.
4. Baeuerle, P. A., and T. Henkel. 1994. Function and activation of NFκB in the immune system. Annu. Rev. Immunol. 12:141-179.
5. 4a.Balsano, C. Unpublished data.
6. Beasley, R. P., C. C. Lin, L. Y. Hwang, and C. S. Chien. 1981 Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22,707 men in Taiwan Lancet ii:1129-1133.
7. Beg, A. A., and A. S. Baldwin. 1993 The IκB proteins: multifunctional regulators of Rel/NFκB transcription factors. Genes Dev. 7:2064-2070.
8. Benn, J., and R. J. Schneider. 1994. Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf MAP kinase signalling cascade. Proc. Natl, Acad Sci USA 91:10350-10354.
9. Bours, V., G. Franzoso, V. Azarenko, S. Park, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein bcl-3 directly trans-activates through κB motifs via association with DNA-binding p50B homodimers. Cell 71:729-739.
10. Bruder, J. T., G. Heidecker, and U. R. Rapp. 1992. Serum-, TPA-, and Ras-induced expression from AP1-Ets driven promoters requires Raf-1 kinase. Genes Dev 6:545-556
11. Cheong, J. H., M. K. Yi, Y. Lin, and S. Murakami. 1995. Human RPB5, a subunit shared by eukaryotic nuclear RNA polymerases, binds human hepatitis B virus X protein and may play a role in X transactivation. EMBO J 14:143-150.
12. Colgrove, R. S., S. Gwynn, and D. Ganem. 1989. Transcriptional activation of homologous and heterologous genes by the hepatitis B virus X gene product in cells permissive for viral replication. J. Virol 63:4019-4026.
13. Cross, J. C., P. Wen, and W. J. Rutter. 1993. Transactivation by hepatitis B virus X protein is promiscuous and dependent on mitogen-activated cellular serine/threonine kinases. Proc. Natl. Acad. Sci. USA 90:8078-8082.
14. Devary, Y., C. Rosette, J. DiDonato, and M. Karin. 1993. NFκB activation by ultraviolet light is not dependent on a nuclear signal. Science 261:1442-1445.
15. Feitelson, M. A., M. Zhu, X. L. Duan, and W. T. London. 1993. Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene 8:1109-1117.
16. Finco, T. S., and A. S. Baldwin. 1993. κB site-dependent induction of gene expression by diverse inducers of nuclear factor κB requires Raf-1. J. Biol. Chem. 268:11676-11679.
17. Fisher, M., L. Runkel, and H. Shaller. 1995. HBx protein of hepatitis B virus interacts with the C-terminal portion of a novel human proteasome alpha-subunit. Virus Genes 10:99-102.
18. Franzoso, G., V. Bours, V. Azarenkov, S. Park, M. T. Yamaguchi, T. Kanno, K. Brown, and U. Siebenlist. 1993. The oncoprotein bcl-3 can facilitate NFκB mediated transactivation by removing inhibiting p50 homodimers from select κB sites. EMBO J. 12:3893-3901.
19. Franzoso, G., V. Bours, S. Park, M. T. Yamaguchi, K. Kelly, and V. Siebenlist. 1992. The candidate oncoprotein bcl-3 is an antagonist of p50/NFκB-mediated inhibition Nature (London) 359:339-342.
20. Fujita, T., G. P. Nolan, H. C. Lion, M. L. Scott, and D. Baltimore. 1993 The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NFκB p50 homodimers. Genes Dev 7:1354-1363.
21. Hammarskjold, M. L., and M. C. Simurda. 1992. Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-κB activity. J. Virol. 66:6496-6501.
22. Haviv, I., D. Vaizel, and Y. Shaul. 1995. The X protein of hepatitis B virus coactivates potent activation domains. Mol. Cell Biol 15:1079-1085.
23. Henkel, T., T. Machleidt, I. Alkalay, M. Kronke, Y. Ben-Neriah, and P. A. Baeuerle. 1993. Rapid proteolysis of IκB-α is necessary for activation of transcription factor NFκB. Nature (London) 365:182-185.
24. Herrero, J. A., P. Mathew, and C. V. Paya. 1995. LMP-1 activates NF-κB by targeting the inhibitory molecule IκB-α. J. Virol 69:2168-2174.
25. Hirai, H., T. Suzuki, J. Fujisawa, J. Inoue, and M. Yoshida. 1994. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor κB and induces nuclear translocation of transcription factor NFκB proteins for transcriptional activation. Proc. Natl. Acad. Sci. USA 91:3584-3588.
26. Hohne, M., S. Schaefer, M. Seifer, M. A. Feitelson, D. Paul, and W. H. Gerlich. 1990. Malignant transformation of immortalized transgenic hepatocytes after transfection with hepatitis B virus DNA. EMBO J 9:1137-1145.
27. Kanno, T., K. Brown, G. Franzoso, and U. Siebenlist. 1994. Kinetic analysis of human T-cell leukemia virus type I Tax-mediated activation of NF-κB Mol. Cell. Biol. 14:6443-6451.
28. Kekulè, A. S., U. Lauer, L. Weiss, B. Luber, and P. H. Hofschneider. 1993. Hepatitis B virus transactivator HBx uses a tumor promoter signalling pathway. Nature (London) 361:742-745.
29. Kim, C. M., K. Koike, I. Saito, T. Miyamura, and G. Jay. 1991. HBx gene of hepatitis B virus induces liver cancer in transgenic mice Nature (London) 353:317-320.
30. Koike, K., K. Moriya, H. Yotsuyanagi, S. Iino, and K. Kurokawa. 1994. Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J. Clin. Invest. 94:44-49
31. Lacoste, J., L. Cohen, and J. Hiscott. 1991. NFκB activity in T cells stably expressing the tax protein of human T cell lymphotropic virus type 1. Virology 184:553-562.
32. Lee, T. H., S. J. Elledge, and J. Butel. 1995 Hepatitis B virus X protein interacts with a probable cellular DNA repair protein J Virol. 69:1107-1114.
33. Lenardo, M., and U. Siebenlist. 1994. Bcl-3-mediated nuclear regulation of the NFκB trans-activating factor. Immunol Today 15:145-147.
34. Leung, K., and G. J, Nabel. 1988. HTLV-1 transactivator tax induces interleukin-2 receptor expression through an NFκB-like factor Nature (London) 333:776-778.
35. Levrero, M., C. Balsano, G. Natoli, M. L. Avantaggiati, and E. Elfassi. 1990. Hepatitis B virus X protein trans-activates the long terminal repeats of human immunodeficiency virus types 1 and 2. J Virol. 64:3082-3086.
36. 34a.Liang, T. J. Personal communication.
37. Liliembaum, A., M. Due Dodon, C. Alexandre, L. Gazzolo, and D. Paulin. 1990. Effect of human T-cell leukemia virus Type I Tax protein on activation of the human vimentin gene. J. Virol. 64:256-263
38. Lindholm, P. F., S. J. Marriot, S. D. Gitlin, C. A. Bohan, and J. N. Brady. 1990. Induction of nuclear NFκB DNA binding activity after exposure of lymphoid cells to soluble tax protein New Biol. 2:1034-1043.
39. Lucito, R., and R. J. Schneider. 1992 Hepatitis B virus X protein activates the transcription factor NF-κB without a requirement for protein kinase C. J. Virol. 66:983-991.
40. Maguire, H. F., J. P. Hoeffler, and A. Siddiqui. 1991. HBV X protein alters the DNA binding specificity of CREB and ATF2 by protein-protein inter-actions. Science 252:842-844.
41. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP-1 engages signalling proteins for the tumor necrosis factor receptor family. Cell 80: 389-399
42. Munoz, E., G. Courtois, P. Veschambre, P. Jalinot, and A. Israel. 1994. Tax induces nuclear translocation of NF-κB through dissociation of cytoplasmic completes containing p105 or p100 but does not induce degradation of 1κB-α/MAD3. J. Virol. 68:8035-8044.
43. Natoli, G., M. L. Avantaggiati, P. Chirillo, A. Costanzo, M. Artini, C. Balsano, and M. Levrero. 1994. Induction of the DNA-binding activity of c-Jun/c-Fos heterodimers by the hepatitis B virus transactivator pX. Mol. Cell. Biol. 14:989-998.
44. Natoli, G., M. L. Avantaggiati, P. Chirillo, P. L. Puri, A. Ianni, C. Balsano, and M. Levrero. 1994. Ras- and Raf-dependent activation of c-Jun transcriptional activity by the hepatitis B virus transactivator pX. Oncogene 9:2837-2843.
45. Palombella, V. J., O. J. Rendo, A. L. Goldberg, and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NFκB1 precursor protein and activation of NFκB. Cell 78:773-785.
46. Qadri, I., H. F. Maguire, and A. Siddiqui. 1995. Hepatitis B virus transactivator protein X interacts with the TATA-binding protein Proc Natl. Acad. Sci. USA 92:1003-1007.
47. Schreck, R., R. Grassman, B. Fleckenstein, and P. A. Baeuerle. 1992. Antioxidants selectively suppress activation of NF-κB by human T-cell leukemia virus type I Tax protein. J. Virol. 66:6288-6293.
48. Schweighoffer, F., H. Cai, M. C. Chevallier-Multon, I. Fath, G. Cooper, and B. Tocque. 1993. The Saccaromyces, cerevisiae SDC25 C-domain gene product overcomes the dominant inhibitory activity of Ha-Ras Asn-17. Mol Cell. Biol. 13:39-43.
49. Seto, E., P. J. Mitchell, and T. S. B. Yen. 1988. Transactivation of the human immunodeficiency virus long terminal repeat by the hepatitis B virus X protein Proc Natl. Acad. Sci USA 85:8286-8290.
50. Shirakata, Y., M. Kawada, Y. Fujiki, H. Sano, M. Oda, K. Yaginuma, M. Kobayashi, and K. Koike. 1989. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation of mouse NIH3T3 cells Jpn. J. Cancer Res. 80:617-621.
51. Sun, S. C., J. Elwood, C. Beraud, and W. C. Greene. 1994. Human T-cell leukemia virus type I Tax activation of NF-κB/Rel involves phosphorylation and degradation of IκB-α and ReIA (p65)-mediated induction of the c-rel gene. Mol. Cell. Biol 14:7377-7384.
52. Takada, S., H. Kido, A. Fukutomi, M. Takeshi, and K. Koike. 1994. Interaction of hepatitis B virus X protein with a serine protease, tryptase TL2. as an inhibitor. Oncogene 9:341-348.
53. Tanos, D., and T. Maniatis. 1995. NFκB: a lesson in family values. Cell 80:529-532.
54. Traenckner, E. B. M., S. Wilk, and P. A. Baeuerle. 1994. A proteasome inhibitor prevents activation of NF-κB and stabilizes a newly phosphorylated form of IκB-α. that still bound to NFκB. EMBO J 13:5433-5441.
55. Twu, J. S., K. Chu, and W. S. Robinson. 1989. Hepatitis B virus X gene activated κB-like enhancer sequences in the long terminal repeat of human immunodeficiency virus I. Proc. Natl. Acad. Sci. USA 86:5168-5172.
56. Twu, J. S., and R. H. Schloemer. 1987. Transcriptional trans-activating function of hepatitis B virus. J. Virol. 61:3448-3453.
57. Williams, J. S., and O. M. Andrisani. 1995. The hepatitis B virus X protein targets the basic region-leucine domain of CREB. Proc. Natl. Acad. Sci USA 92:3819-3823.
58. Zahm, P., P. H. Hofschneider, and R. Koshy. 1988. The hepatitis B virus X-ORF encodes a trans-activator. a potential factor in viral hepatocarcinogenesis. Oncogene 3:169-177